Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Persson

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
International Journal of Cardiology|October 28, 2016
Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen studyGianluigi Savarese, Erwan Donal, Camilla Hage, et al.
ESC Heart Failure|February 20, 2020
The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension studyMattias Ekström, Anna Hellman, Jan Hasselström, et al.
International Journal of Cardiology|April 1, 2018
Corrigendum to "Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study" [Int. J. Cardiol. 226 (2017) 65-70]Gianluigi Savarese, Erwan Donal, Camilla Hage, et al.
International Journal of Cardiology|July 28, 2018
Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines - A substudy in the Ka (Karolinska) Ren (Rennes) studyHans Persson, Erwan Donal, Lars H Lund, et al.
European Heart Journal. Cardiovascular Imaging|June 18, 2015
Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen studyErwan Donal, Lars H Lund, Emmanuel Oger, et al.
Journal of the American College of Cardiology|February 13, 2007
Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMESHans Persson, Eva Lonn, Magnus Edner, et al.
ESC Heart Failure|December 1, 2020
Adherence to beta-blockers and long-term risk of heart failure and mortality after a myocardial infarctionLiyew Desta, Masih Khedri, Tomas Jernberg, et al.
European Journal of Heart Failure|July 8, 2016
Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitantsCecilia Linde, Maria J Eriksson, Camilla Hage, et al.
Journal of Cardiac Failure|March 14, 2020
Increased iron absorption in patients with chronic heart failure and iron deficiencyCarin C Cabrera, Mattias Ekström, Cecilia Linde, et al.
European Heart Journal Open|April 3, 2025
Baseline characteristics and 1-year outcome by left ventricular function in the CABG PREFERSUlrika Löfström, Cecilia Linde, Maria J Eriksson, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
International Journal of Cardiology|October 28, 2016
Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen studyGianluigi Savarese, Erwan Donal, Camilla Hage, et al.
ESC Heart Failure|February 20, 2020
The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension studyMattias Ekström, Anna Hellman, Jan Hasselström, et al.
International Journal of Cardiology|April 1, 2018
Corrigendum to "Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study" [Int. J. Cardiol. 226 (2017) 65-70]Gianluigi Savarese, Erwan Donal, Camilla Hage, et al.
International Journal of Cardiology|July 28, 2018
Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines - A substudy in the Ka (Karolinska) Ren (Rennes) studyHans Persson, Erwan Donal, Lars H Lund, et al.
European Heart Journal. Cardiovascular Imaging|June 18, 2015
Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen studyErwan Donal, Lars H Lund, Emmanuel Oger, et al.
Journal of the American College of Cardiology|February 13, 2007
Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMESHans Persson, Eva Lonn, Magnus Edner, et al.
ESC Heart Failure|December 1, 2020
Adherence to beta-blockers and long-term risk of heart failure and mortality after a myocardial infarctionLiyew Desta, Masih Khedri, Tomas Jernberg, et al.
European Journal of Heart Failure|July 8, 2016
Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitantsCecilia Linde, Maria J Eriksson, Camilla Hage, et al.
Journal of Cardiac Failure|March 14, 2020
Increased iron absorption in patients with chronic heart failure and iron deficiencyCarin C Cabrera, Mattias Ekström, Cecilia Linde, et al.
European Heart Journal Open|April 3, 2025
Baseline characteristics and 1-year outcome by left ventricular function in the CABG PREFERSUlrika Löfström, Cecilia Linde, Maria J Eriksson, et al.
Pageof 9